The long term goal of this study is to determine if and how neoplastic progression can be interrupted by immunization with monclonal anti-idiotypic antibodies that resemble (R) the antigenic structures (epitopes-E) on preneoplastic and/or neoplastic mammary lesions -monoclonal anti-Id(RE). The test system is the transplantable, preneoplastic, hyperplastic alveolar nodule (HAN) lines and the tumors which develop spontaneously from them in strain BALB/c mice.
The specific aims are: 1) prepare monoclonal, anti-idiotypic antibodies against monoclonal antibodies (MoAbs) directed to HANs and/or their sponstaneous tumors; 2) select monoclonal anti-Ids that resemble the mammary lesion epitopes and determine their immunogenicity; 3) determine the growth and tumorigenicity of HANs and tumors in mice immunized with monoclonal anti-Id(RE). The questions we wish to address are whether immunization with anti-idiotype antibodies is an effective way of stimulating lymphocytes, and if so, whether the results will be modulation of neoplastic progression. The otucome of our studies is important to furthering our understanding of the mechanisms of progression and to pointing to a possible direction for immunoprevention of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA042522-01A1
Application #
3183961
Study Section
Experimental Immunology Study Section (EI)
Project Start
1987-04-01
Project End
1990-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Barbara Ann Karmanos Cancer Institute
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48201
Gill, R; Wang, H; Bluethmann, H et al. (1994) Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice. Cancer Res 54:1529-35
Wang, H; Gill, R F; Lichlyter, D et al. (1994) Deletion of CD4+ T cells and thymocytes by apoptosis in mouse mammary tumor virus (C4)-infected V beta 2 transgenic mice. Eur J Immunol 24:2950-6
Shakhov, A N; Wang, H; Acha-Orbea, H et al. (1993) A new infectious mammary tumor virus in the milk of mice implanted with C4 hyperplastic alveolar nodules. Eur J Immunol 23:2765-9
Wei, W Z; Gill, R F; Wang, H (1993) Mouse mammary tumor virus associated antigens and superantigens--immuno-molecular correlates of neoplastic progression. Semin Cancer Biol 4:205-13
Wei, W Z; Wang, H; Ficsor-Jacobs, R et al. (1992) Adoptive transfer of V beta 2-deleting activity with host cells from mice implanted with C4 preneoplastic hyperplastic alveolar nodules. Cancer Res 52:5183-9
Wei, W Z; Ficsor-Jacobs, R; Tsai, S J et al. (1991) Elimination of V beta 2 bearing T-cells in BALB/c mice implanted with syngeneic preneoplastic and neoplastic mammary lesions. Cancer Res 51:3331-3
Maloney, T; Wei, W Z (1990) Two-dimensional gel analysis of polypeptides from normal, preneoplastic and neoplastic mouse mammary tissues. Cancer Immunol Immunother 30:367-73
Wei, W Z; Fisher, S; Kohler, H (1989) Improved anti-tumor reactivity with monoclonal anti-idiotypic antibody conjugated to syngeneic mouse red blood cells. J Immunol Methods 122:227-34
Wei, W Z; Ratner, S (1987) A new assay to measure monoclonal antibody-dependent complement or macrophage-mediated tumor growth inhibition. J Immunol Methods 102:53-8